About Esya Labs
Esya Labs is a company based in United Kingdom founded in 2017 by Dhivya Venkat. Esya Labs has raised $217.22 thousand across 2 funding rounds. The company has 5 employees as of January 31, 2022. Esya Labs offers products and services including NULISA Platform, Voltair, CalipHluor, Clensor, and NOckout. Esya Labs operates in a competitive market with competitors including 10X Genomics, Nanopore, PacBio, Omniome and Complete Genomics, among others.
- Headquarter United Kingdom
- Employees 5 as on 31 Jan, 2022
- Founders Dhivya Venkat
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Esya Ltd
- Date of Incorporation 15 Aug, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$217.22 K (USD)
in 2 rounds
-
Latest Funding Round
$67.22 K (USD), Seed
Jun 13, 2022
-
Investors
Not available
-
Employee Count
5
as on Jan 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Esya Labs
Esya Labs offers a comprehensive portfolio of products and services, including NULISA Platform, Voltair, CalipHluor, Clensor, and NOckout.
Platform for high-sensitivity biomarker detection in neurodegenerative research.
Sensor for measuring membrane potential in neurological diseases.
Ratiometric tool for pH and calcium detection in brain disorders.
Multiplex-enabled sensor for lysosomal storage disorder analysis.
Ratiometric probe for detecting nitric oxide in various diseases.
People of Esya Labs
Unlock access to complete
Unlock access to complete
Funding Insights of Esya Labs
Esya Labs has successfully raised a total of $217.22K across 2 strategic funding rounds. The most recent funding activity was a Seed round of $67.22 thousand completed in June 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investments & Acquisitions by Esya Labs
Investment portfolio details for Esya Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Esya Labs
Detailed financials for Esya Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Esya Labs Comparisons
Peer comparison for Esya Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Esya Labs
Esya Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, Nanopore, PacBio, Omniome and Complete Genomics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Instrument systems for genomic research and sequencing libraries are developed.
|
|
| Locked | Locked | Locked |
Nanopore-based electronic systems for single-molecule analysis are developed.
|
|
| Locked | Locked | Locked |
Instrument systems and software for single-molecule real-time sequencing are developed.
|
|
| Locked | Locked | Locked |
Genome sequencing platform is provided for clinical diagnostics.
|
|
| Locked | Locked | Locked |
DNA sequencing platform for human genome analysis is developed.
|
|
| Locked | Locked | Locked |
Benchtop DNA sequencers are developed for research and diagnostic uses.
|
Detailed competitors of Esya Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Esya Labs
Complete news archive for Esya Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Esya Labs
Esya Labs was founded in 2017 and raised its 1st funding round 2 years after it was founded.
Esya Labs is headquartered in United Kingdom.
Esya Labs is a funded company, having raised a total of $217.22K across 2 funding rounds to date.
As of Jan 31, 2022, the latest employee count at Esya Labs is 5.
Esya Labs was founded in 2017 in the United Kingdom as a biotechnology firm focused on nanotechnology. Nucleic acid diagnostics are developed by the company to enable early detection of diseases, with an emphasis on rare genetic conditions. Operations center on advancing safe diagnostic technologies, targeting applications in healthcare for improved disease identification and management.
Esya Labs's top competitors include Nanopore, 10X Genomics and PacBio.
Esya Labs offers NULISA Platform, Voltair, CalipHluor, Clensor, and NOckout.